Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Department of Medicine and Lawson Health Research Institute

London Health Sciences Centre Department of Physiology & Pharmacology

University of Western Ontario

London

Canada

Name/email consistency: high

Department of Medicine and Lawson Health Research Institute, London Health Sciences Centre Department of Physiology & Pharmacology, University of Western Ontario, London, Canada. 2007 - 2010
Department of Medicine, London Health Sciences Centre, Ontario, Canada. 1998 - 2004

Fruit juice inhibition of uptake transport: a new type of food-drug interaction. Bailey, D.G. Br. J. Clin. Pharmacol (2010) [Pubmed]
Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Bailey, D.G., Dresser, G.K., Leake, B.F., Kim, R.B. Clin. Pharmacol. Ther. (2007) [Pubmed]
Interactions between grapefruit juice and cardiovascular drugs. Bailey, D.G., Dresser, G.K. Am. J. Cardiovasc. Drugs (2004) [Pubmed]
Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice. Bailey, D.G., Dresser, G.K., Bend, J.R. Clin. Pharmacol. Ther. (2003) [Pubmed]
Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients. Bailey, D.G., Dresser, G.K., Kreeft, J.H., Munoz, C., Freeman, D.J., Bend, J.R. Clin. Pharmacol. Ther. (2000) [Pubmed]
Grapefruit juice-felodipine interaction: effect of naringin and 6',7'-dihydroxybergamottin in humans. Bailey, D.G., Kreeft, J.H., Munoz, C., Freeman, D.J., Bend, J.R. Clin. Pharmacol. Ther. (1998) [Pubmed]